List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Versantis Company

Versantis is a Swiss pharmaceutical company developing medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide.

Its lead candidate, VS-01, is currently at the preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcomes in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.

Versantis was established in 2015 by Meriam Kabbaj in Zurich, Switzerland.

Investors

Employee Number: 1-10
Headquarters: Zürich, Zurich, Switzerland, Europe
Founded Date: 2015-01-01
Industry: Drug Discovery & Development
Super Industry: Biopharma & Life Science Tools
Phone Number: +41446330672
Investors: Altus Capital Partners, Venture Kick, Verve Ventures, Z?rcher Kantonal Bank, redalpine
Ipo Status: private
City: Zürich
Region: Zurich
Country: Switzerland
Founders: Meriam Kabbaj
Register and Claim Ownership